ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC33141-100mg |
|
1370256-78-2 |
SKLB4771 (FLT3-?IN-?1)
|
0 | C25H27N7O3S2 | |
GC33141-50mg |
|
1370256-78-2 |
SKLB4771 (FLT3-?IN-?1)
|
0 | C25H27N7O3S2 | |
GC33141-10mg |
|
1370256-78-2 |
SKLB4771 (FLT3-?IN-?1)
|
0 | C25H27N7O3S2 | |
GC33141-5mg |
|
1370256-78-2 |
SKLB4771 (FLT3-?IN-?1)
|
0 | C25H27N7O3S2 | |
GC33141-2mg |
|
1370256-78-2 |
SKLB4771 (FLT3-?IN-?1)
|
0 | C25H27N7O3S2 | |
GC33141-10mM(1mLinDMSO) |
|
1370256-78-2 |
SKLB4771 (FLT3-?IN-?1)
|
0 | C25H27N7O3S2 | |
GC33140-5mg |
|
2140-67-2 |
N2,N2-Dimethylguanosine
|
0 | C12H17N5O5 | |
GC33140-10mM(1mLinDMSO) |
|
2140-67-2 |
N2,N2-Dimethylguanosine
|
0 | C12H17N5O5 | |
GC33139-10mg |
|
28448-85-3 |
Bavachalcone (Broussochalcone B)
|
0 | C20H20O4 | |
GC33139-5mg |
|
28448-85-3 |
Bavachalcone (Broussochalcone B)
|
0 | C20H20O4 | |
GC33139-10mM(1mLinDMSO) |
|
28448-85-3 |
Bavachalcone (Broussochalcone B)
|
0 | C20H20O4 | |
GC33138-20mg |
|
1007581-62-5 |
Cancer-Targeting Compound 1
|
0 | C15H13N3O2S | |
GC33138-10mg |
|
1007581-62-5 |
Cancer-Targeting Compound 1
|
0 | C15H13N3O2S | |
GC33138-5mg |
|
1007581-62-5 |
Cancer-Targeting Compound 1
|
0 | C15H13N3O2S | |
GC33138-1mg |
|
1007581-62-5 |
Cancer-Targeting Compound 1
|
0 | C15H13N3O2S | |
GC33137-50mg |
|
1609522-33-9 |
SEL120-34A
|
0 | C15H18Br2N4 | |
GC33137-10mg |
|
1609522-33-9 |
SEL120-34A
|
0 | C15H18Br2N4 | |
GC33137-5mg |
|
1609522-33-9 |
SEL120-34A
|
0 | C15H18Br2N4 | |
GC33137-1mg |
|
1609522-33-9 |
SEL120-34A
|
0 | C15H18Br2N4 | |
GC33136-10mg |
|
1436391-86-4 |
PF-06380101
|
0 | C39H62N6O6S | |